Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc. (NASDAQ:OFIX), filed a Form 4 on August 20, 2026, disclosing the sale of 1,295 shares of common stock on August 18, 2026, to satisfy tax withholding obligations connected to the settlement of restricted stock units.

Key Highlights

  • Shares sold: 1,295 shares of Orthofix Medical common stock were disposed of on 08/18/2026.
  • Sale price: Shares were sold at $10.09 per share.
  • Purpose of sale: The sale was made solely to satisfy tax withholding obligations upon settlement of restricted stock units, under a pre-existing sell-to-cover requirement mandated by the Compensation and Talent Development Committee.
  • No personal discretion: According to the filing, "such sale was made without the exercise of any discretion by the reporting person."
  • Beneficial ownership following transaction: Fisher directly holds 51,219 shares of common stock following the reported transaction.
  • Included in total: The 51,219 shares include 36,028 previously reported restricted stock units and 1,881 shares acquired under Orthofix's Stock Purchase Plan on 04/30/2026.

Patrick Fisher's RSU Settlement and Tax-Withholding Sale at Orthofix Medical

According to the Form 4 filed with the SEC on August 20, 2026, Patrick Fisher, who serves as President of Global Limb Recon at Orthofix Medical Inc., reported a single transaction in Table I involving the disposition of 1,295 shares of common stock. The transaction code recorded is "S," and the sale took place on August 18, 2026, at a price of $10.09 per share. The filing identifies Fisher's address as 3451 Plano Parkway, Lewisville, Texas 75056.

The filing explains that the shares were sold to cover tax withholding obligations arising from the settlement of restricted stock units. The sale was carried out pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the company's Board of Directors, acting as administrator of the plan under which the restricted stock units were granted. The filing states the transaction was executed without any discretion on Fisher's part.

Following the reported transaction, Fisher directly beneficially owns 51,219 shares of common stock. The filing notes that this total includes 36,028 previously reported restricted stock units and 1,881 shares acquired under Orthofix's Stock Purchase Plan on April 30, 2026. The filing further notes that Orthofix's Stock Purchase Plan qualifies as a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and that share acquisitions under the plan are exempt from Section 16(b). The Form 4 was signed by J. Andres Cedron as attorney-in-fact on August 20, 2026.

What Was Disclosed

Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc., disclosed the sale of 1,295 common shares at $10.09 on August 18, 2026, for tax withholding purposes upon RSU settlement, leaving him with direct beneficial ownership of 51,219 shares.